Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of KindaPed vs Derbac-M for head lice treatment
2007-001872-36Phase 3Completed
- Sponsor
- EctoPharma
- Start
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of KindaPed in pediculosis capitis (3 arms), sponsored by EctoPharma. Primary endpoint: Cure or re-infestation rate after two treatment applications. Started Feb 2008; status: completed.
02
Drugs
KindaPed
03
Conditions
pediculosis capitis
Beyond the preview
Go deeper on 2007-001872-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001872-36.